REDUCTION IN PLASMA LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND URINARY MEVALONIC ACID BY LOVASTATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引：45
|
作者：
PAPPU, AS [1 ]
ILLINGWORTH, DR [1 ]
BACON, S [1 ]
机构：
[1] OREGON HLTH SCI UNIV, DEPT MED, DIV ENDOCRINOL METAB & CLIN NUTR, L465, PORTLAND, OR 97201 USA
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 1989年 / 38卷 / 06期
关键词：
D O I：
10.1016/0026-0495(89)90214-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：542 / 549
页数：8
相关论文
共 50 条
  • [11] Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)
    Agha, Ali M.
    Jones, Peter H.
    Ballantyne, Christie M.
    Virani, Salim S.
    Nambi, Vijay
    JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (05) : 649 - 652
  • [12] Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia
    Nomura, Akihiro
    Sato, Takehiro
    Tada, Hayato
    Kannon, Takayuki
    Hosomichi, Kazuyoshi
    Tsujiguchi, Hiromasa
    Nakamura, Hiroyuki
    Takamura, Masayuki
    Tajima, Atsushi
    Kawashiri, Masa-aki
    JOURNAL OF HUMAN GENETICS, 2021, 66 (11) : 1079 - 1087
  • [13] EFFECTS OF FENOFIBRATE ON HIGH AND LOW-DENSITY LIPOPROTEIN METABOLISM IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    MALMENDIER, CL
    DELCROIX, C
    ATHEROSCLEROSIS, 1985, 55 (02) : 161 - 169
  • [14] Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia
    Akihiro Nomura
    Takehiro Sato
    Hayato Tada
    Takayuki Kannon
    Kazuyoshi Hosomichi
    Hiromasa Tsujiguchi
    Hiroyuki Nakamura
    Masayuki Takamura
    Atsushi Tajima
    Masa-aki Kawashiri
    Journal of Human Genetics, 2021, 66 : 1079 - 1087
  • [15] LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL IMMUNOPHERESIS IN TREATING 3 PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    KUKHARCHUK, VV
    KONOVALOV, GA
    KURDANOV, KA
    VEDERNIKOV, AY
    POKROVSKY, SN
    ALFERYEV, AM
    KHASHIMOV, KA
    ARTIFICIAL ORGANS, 1988, 12 (03) : 277 - 277
  • [16] Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
    Nenseter, Marit S.
    Narverud, Ingunn
    Graesdal, Asgeir
    Bogsrud, Martin P.
    Aukrust, Pal
    Retterstol, Kjetil
    Ose, Leiv
    Halvorsen, Bente
    Holven, Kirsten B.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (02) : 109 - 116
  • [17] Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia
    Higashikata, T
    Mabuchi, H
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (04): : 402 - 407
  • [18] Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia
    Goldammer, A
    Wiltschnig, S
    Heinz, G
    Jansen, M
    Stulnig, T
    Hörl, WH
    Derfler, K
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (08): : 976 - 980
  • [19] Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia
    Sánchez-Quesada, JL
    Otal-Entraigas, C
    Franco, M
    Jorba, O
    González-Sastre, F
    Blanco-Vaca, F
    Ordóñez-Llanos, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (06): : 655 - 659
  • [20] Balancing Low-density Lipoprotein Cholesterol Reduction and Hepatotoxicity With Lomitapide Mesylate and Mipomersen in Patients With Homozygous Familial Hypercholesterolemia
    Won, Jane I.
    Zhang, Jun
    Tecson, Kristen M.
    McCullough, Peter A.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2017, 18 (01) : 21 - 28
12345